Thalassemia conference addresses blood supply and patient rights
AI-generated image
AI Synthesis Sources: 5

Thalassemia conference addresses blood supply and patient rights

The Thalassemia2026Cy conference took place in Paphos on November 13-14, 2026, bringing together health officials, researchers, and patient advocates to discuss advancements in care and the management of blood shortages. Minister of Health Neofytos Charalambidis emphasized the necessity of strengthening blood donation efforts and leveraging modern scientific progress to improve treatment outcomes for thalassemia patients.

During the event, Patient Ombudsman Marios Charalambidis highlighted significant concerns regarding recent instances of delayed transfusions and suboptimal dosing at thalassemia centers. He explicitly stated that blood transfusions are non-elective, life-sustaining treatments comparable to chemotherapy or dialysis, and should never be postponed due to staffing or scheduling issues. To rectify these systemic challenges, the Ombudsman proposed the establishment of a dedicated safety reserve of blood specifically for multi-transfused patients. He further argued that medical decisions regarding transfusion thresholds must be guided solely by the clinical needs of the individual patient rather than current fluctuations in blood bank inventory levels. These recommendations are intended to be integrated into the implementation of the national blood strategy to ensure consistent and uninterrupted care.

Original Sources